Exact Mass: 418.2387386
Exact Mass Matches: 418.2387386
Found 500 metabolites which its exact mass value is equals to given mass value 418.2387386
,
within given mass tolerance error 0.05 dalton. Try search metabolite list with more accurate mass tolerance error
0.01 dalton.
Phyllanthin
Phyllanthin is a major bioactive lignan component of Phyllanthus amarus. Phyllanthin exhibits high antioxidative and hepatoprotective properties[1]. Phyllanthin is a major bioactive lignan component of Phyllanthus amarus. Phyllanthin exhibits high antioxidative and hepatoprotective properties[1].
4,4-(Diphenylethenylidene)bis[N,N-dimethylbenzenamine]
2alpha-Methylcortisol acetate
CPA(18:1(11Z)/0:0)
cPA(18:1(11Z)/0:0) is a cyclic phosphatidic acid or cyclic lysophosphatidic acid. It is a glycerophospholipid in which a cyclic phosphate moiety occupies two glycerol substitution sites. Lysophosphatidic acids can have different combinations of fatty acids of varying lengths and saturation attached at the C-1 (sn-1). Fatty acids containing 16 and 18 carbons are the most common. Cyclic phosphatidic acids have been detected in a wide range of organisms including humans, especially in the brain but also in serum (at a concentration of 10-7M). cPAs have a cyclic phosphate at the sn-2 and sn-3 positions of the glycerol carbons, and this structure is absolutely necessary for their activities. In particular, it is found in tissues subject to injury, and while it may have some similar signalling functions to lysophosphatidic acid per se, it also has some quite distinct biological activities. For example, cyclic phosphatidic acid is known to be a specific inhibitor of DNA polymerase alpha. It has an appreciable effect on the inhibition of cancer cell invasion and metastasis. [HMDB] cPA(18:1(11Z)/0:0) is a cyclic phosphatidic acid or cyclic lysophosphatidic acid. It is a glycerophospholipid in which a cyclic phosphate moiety occupies two glycerol substitution sites. Lysophosphatidic acids can have different combinations of fatty acids of varying lengths and saturation attached at the C-1 (sn-1). Fatty acids containing 16 and 18 carbons are the most common. Cyclic phosphatidic acids have been detected in a wide range of organisms including humans, especially in the brain but also in serum (at a concentration of 10-7M). cPAs have a cyclic phosphate at the sn-2 and sn-3 positions of the glycerol carbons, and this structure is absolutely necessary for their activities. In particular, it is found in tissues subject to injury, and while it may have some similar signalling functions to lysophosphatidic acid per se, it also has some quite distinct biological activities. For example, cyclic phosphatidic acid is known to be a specific inhibitor of DNA polymerase alpha. It has an appreciable effect on the inhibition of cancer cell invasion and metastasis.
CPA(18:1(9Z)/0:0)
cPA(18:1(9Z)/0:0) is a cyclic phosphatidic acid or cyclic lysophosphatidic acid. It is a glycerophospholipid in which a cyclic phosphate moiety occupies two glycerol substitution sites. Lysophosphatidic acids can have different combinations of fatty acids of varying lengths and saturation attached at the C-1 (sn-1). Fatty acids containing 16 and 18 carbons are the most common. Cyclic phosphatidic acids have been detected in a wide range of organisms including humans, especially in the brain but also in serum (at a concentration of 10-7M). cPAs have a cyclic phosphate at the sn-2 and sn-3 positions of the glycerol carbons, and this structure is absolutely necessary for their activities. In particular, it is found in tissues subject to injury, and while it may have some similar signalling functions to lysophosphatidic acid per se, it also has some quite distinct biological activities. For example, cyclic phosphatidic acid is known to be a specific inhibitor of DNA polymerase alpha. It has an appreciable effect on the inhibition of cancer cell invasion and metastasis. [HMDB] cPA(18:1(9Z)/0:0) is a cyclic phosphatidic acid or cyclic lysophosphatidic acid. It is a glycerophospholipid in which a cyclic phosphate moiety occupies two glycerol substitution sites. Lysophosphatidic acids can have different combinations of fatty acids of varying lengths and saturation attached at the C-1 (sn-1). Fatty acids containing 16 and 18 carbons are the most common. Cyclic phosphatidic acids have been detected in a wide range of organisms including humans, especially in the brain but also in serum (at a concentration of 10-7M). cPAs have a cyclic phosphate at the sn-2 and sn-3 positions of the glycerol carbons, and this structure is absolutely necessary for their activities. In particular, it is found in tissues subject to injury, and while it may have some similar signalling functions to lysophosphatidic acid per se, it also has some quite distinct biological activities. For example, cyclic phosphatidic acid is known to be a specific inhibitor of DNA polymerase alpha. It has an appreciable effect on the inhibition of cancer cell invasion and metastasis.
Phenylalanyl-prolyl-arginine
Palosuran
C25H30N4O2 (418.23686399999997)
Phyllanthin
MFA
Mfa is practically insoluble (in water) and an extremely weak acidic compound (based on its pKa). Mfa can be found in french plantain, which makes mfa a potential biomarker for the consumption of this food product. MFA may refer to: .
19-(Dimethylarsinoyl)nonadecanoic acid
C21H43AsO3 (418.24279879999995)
2-(11,17-Dihydroxy-10,13,16-trimethyl-3-oxo-4,5,6,7,8,9,10,11,12,13,14,15,16,17-tetradecahydro-3H-cyclopenta[a]phenanthren-17-yl)-2-oxoethyl acetate
methyl (4R,8aS)-1-hydroxy-2-(hydroxymethyl)-5,5,8a-trimethyl-4-[(2E,4E,6E)-octa-2,4,6-trienoyl]oxy-4a,6,7,8-tetrahydro-4H-naphthalene-1-carboxylate
7alpha,15-dihydroxy-8,11,13-abietatriene-18-succinic acid|abiesadine L
14beta-hydroxy-3beta,7alpha-diacetoxy-ent-kaur-16-en-15-one|racemosin A
8-acetyl-3alpha-hydroperoxy-2alpha-isohex-3-enyl-6-isopent-2-enyl-5-methoxy-2beta-methylchroman-7-ol
ent-1alpha,7beta-diacetoxy-14alpha-hydroxykaur-15-oxo-16-ene|ent-1??,7??-Diacetoxy-14??-hydroxykaur-16-en-15-one
ent-11alpha,18-diacetoxy-7beta-hydroxykaur-16-en-15-one|ent-11??,18-Diacetoxy-7??-hydroxykaur-16-en-15-one
14beta-acetoxy-15alpha-methoxyl-3alpha-(4-methylsenecioyloxy)-14alpha,15beta-epoxy-alpha-isocedrene|14beta-acetoxy-15alpha-methoxyl-3alpha-<4-methylsenecioyloxy>-14alpha,15beta-epoxy-alpha-isocedrene
16-formate gitoxigenin|16beta-Formyloxy-3beta,14-dihydroxy-5beta,14beta-card-20(22)-enolid|16beta-formyloxy-3beta,14-dihydroxy-5beta,14beta-card-20(22)-enolide|3beta,14,16beta-trihydroxy-5beta-card-20(22)-enolide 16-formate|ditaloxigenin 16beta-formate
11,16-diacetoxyoctadeca-17-ene-12,14-diynyl acetate|11,16-diacetoxyoctadeca-17-ene-12,14-diynyl ethanoate
(1S*,2R*,4R*,7R*,10R*)-1,7,10,11-tetrahydroxy-1,7,11-trimethyl-4,10(H)-2-O-cinnamoyl-bisabol-8(9)-ene
4,7:14,16-Diepoxy-1(14),11,15-cembratriene-2,3-diol-2,3-Di-Ac
19-dimethylarsinoyl-nonadecanoic acid
C21H43AsO3 (418.24279879999995)
(19S)-3beta,19-epoxy-2alpha,3beta,14beta-trihydroxy-19-methoxy-5alpha-card-20(22)enolide
(-)-(12E,2S,3S,4R,5R,6R,9S,11S,15R)-3,15-diacetoxy-5,6-epoxylathyr-12-en-14-one
A lathyrane diterpenoid isolated from the roots of Euphorbia micractina.
Di-Ac-18,19-Dihydroxy-3,13-clerodadien-15,16-olide
ent-1alpha,14alpha-diacetoxy-7beta-hydroxykaur-16-en-15-one
2beta,19-epoxy-3beta,14beta-dihydroxy-19-methoxy-5alpha-card-20(22)-enolide
(2R,5S,8R,9R,10S,18R,19S)-18,19-diacetoxy-18,19-epoxy-2-hydroxy-cleroda-3,12(Z),14-triene|caseargrewiin D
8beta-acetoxy-3beta-(4-methylsenecioyloxy)-isocostic acid methyl ester|8beta-acetoxy-3beta-<4-methylsenecioyloxy>-isocostic acid methyl ester
7beta,11beta-diacetoxy-spongia-13-en-16-one|dorisenone C
7beta-hydroxy-17-succinyloxy-15,16-epoxy-ent-cleroda-3,13(16),14-triene
12beta,14beta-dihydroxy-3beta,19-epoxy-3alpha-methoxy-5alpha-card-20(22)enolide
15,16-di-O-acetyl-2,7-dioxofagonene|Di-Ac-15,16-Dihydroxy-3-erythroxylene-2,7-dione
Isodopharicin B|isodopharicin B; acetylisodopharicin A
17-hydroxy-7beta-succinyloxy-15,16-epoxy-ent-cleroda-3,13(16),14-triene
75O1TFF47Z
Phyllanthin is a lignan. Phyllanthin is a natural product found in Phyllanthus debilis, Phyllanthus amarus, and other organisms with data available. See also: Phyllanthus amarus top (part of). Phyllanthin is a major bioactive lignan component of Phyllanthus amarus. Phyllanthin exhibits high antioxidative and hepatoprotective properties[1]. Phyllanthin is a major bioactive lignan component of Phyllanthus amarus. Phyllanthin exhibits high antioxidative and hepatoprotective properties[1].
4-[(2R,3R)-3-[(3,4-dimethoxyphenyl)methyl]-4-methoxy-2-(methoxymethyl)butyl]-1,2-dimethoxybenzene
C24H34O6_Methyl (4R,8aS)-1-hydroxy-2-(hydroxymethyl)-5,5,8a-trimethyl-4-[(2E,4E,6E)-2,4,6-octatrienoyloxy]-1,4,4a,5,6,7,8,8a-octahydro-1-naphthalenecarboxylate
4-[(2R,3R)-3-[(3,4-dimethoxyphenyl)methyl]-4-methoxy-2-(methoxymethyl)butyl]-1,2-dimethoxybenzene
4-[(2R,3R)-3-[(3,4-dimethoxyphenyl)methyl]-4-methoxy-2-(methoxymethyl)butyl]-1,2-dimethoxybenzene [IIN-based: Match]
4-[(2R,3R)-3-[(3,4-dimethoxyphenyl)methyl]-4-methoxy-2-(methoxymethyl)butyl]-1,2-dimethoxybenzene [IIN-based on: CCMSLIB00000848940]
methyl (4R,8aS)-1-hydroxy-2-(hydroxymethyl)-5,5,8a-trimethyl-4-[(2E,4E,6E)-octa-2,4,6-trienoyl]oxy-4a,6,7,8-tetrahydro-4H-naphthalene-1-carboxylate_major
Gly Val Met Leu
C18H34N4O5S (418.22497940000005)
Ile Cys Ala Leu
C18H34N4O5S (418.22497940000005)
Ile Cys Ile Ala
C18H34N4O5S (418.22497940000005)
Ile Cys Leu Ala
C18H34N4O5S (418.22497940000005)
Ile Gly Met Val
C18H34N4O5S (418.22497940000005)
Ile Gly Val Met
C18H34N4O5S (418.22497940000005)
Ile Ile Ala Cys
C18H34N4O5S (418.22497940000005)
Ile Ile Cys Ala
C18H34N4O5S (418.22497940000005)
Ile Ile Ser Ser
Ile Leu Ala Cys
C18H34N4O5S (418.22497940000005)
Ile Leu Cys Ala
C18H34N4O5S (418.22497940000005)
Ile Leu Ser Ser
Ile Met Gly Val
C18H34N4O5S (418.22497940000005)
Ile Met Val Gly
C18H34N4O5S (418.22497940000005)
Ile Ser Ile Ser
Ile Ser Leu Ser
Ile Ser Ser Ile
Ile Ser Ser Leu
Ile Ser Thr Val
Ile Ser Val Thr
Ile Thr Ser Val
Ile Thr Val Ser
Ile Val Ser Thr
Ile Val Thr Ser
Leu Ala Leu Cys
C18H34N4O5S (418.22497940000005)
Leu Cys Ala Ile
C18H34N4O5S (418.22497940000005)
Leu Cys Ala Leu
C18H34N4O5S (418.22497940000005)
Leu Cys Ile Ala
C18H34N4O5S (418.22497940000005)
Leu Cys Leu Ala
C18H34N4O5S (418.22497940000005)
Leu Gly Met Val
C18H34N4O5S (418.22497940000005)
Leu Gly Val Met
C18H34N4O5S (418.22497940000005)
Leu Ile Ala Cys
C18H34N4O5S (418.22497940000005)
Leu Ile Cys Ala
C18H34N4O5S (418.22497940000005)
Leu Ile Ser Ser
Leu Leu Ala Cys
C18H34N4O5S (418.22497940000005)
Leu Leu Cys Ala
C18H34N4O5S (418.22497940000005)
Leu Leu Ser Ser
Leu Met Gly Val
C18H34N4O5S (418.22497940000005)
Leu Met Val Gly
C18H34N4O5S (418.22497940000005)
Leu Ser Ile Ser
Leu Ser Leu Ser
Leu Ser Ser Ile
Leu Ser Ser Leu
Leu Ser Thr Val
Leu Ser Val Thr
Leu Thr Ser Val
Leu Thr Val Ser
Leu Val Gly Met
C18H34N4O5S (418.22497940000005)
Leu Val Met Gly
C18H34N4O5S (418.22497940000005)
Leu Val Ser Thr
Leu Val Thr Ser
Ser Ile Ile Ser
Ser Ile Leu Ser
Ser Ile Ser Ile
Ser Ile Ser Leu
Ser Ile Thr Val
Ser Ile Val Thr
Ser Leu Ile Ser
Ser Leu Leu Ser
Ser Leu Ser Ile
Ser Leu Ser Leu
Ser Leu Thr Val
Ser Leu Val Thr
Ser Ser Ile Ile
Ser Ser Ile Leu
Ser Ser Leu Ile
Ser Ser Leu Leu
Ser Thr Ile Val
Ser Thr Leu Val
Ser Thr Val Ile
Ser Thr Val Leu
Ser Val Ile Thr
Ser Val Leu Thr
Ser Val Thr Ile
Ser Val Thr Leu
Thr Ile Ser Val
Thr Ile Val Ser
Thr Leu Ser Val
Thr Leu Val Ser
Thr Ser Ile Val
Thr Ser Leu Val
Thr Ser Val Ile
Thr Ser Val Leu
Thr Thr Val Val
Thr Val Ile Ser
Thr Val Leu Ser
Thr Val Ser Ile
Thr Val Ser Leu
Thr Val Thr Val
Thr Val Val Thr
Val Ala Val Met
C18H34N4O5S (418.22497940000005)
Val Cys Val Val
C18H34N4O5S (418.22497940000005)
Val Gly Ile Met
C18H34N4O5S (418.22497940000005)
Val Gly Leu Met
C18H34N4O5S (418.22497940000005)
Val Gly Met Ile
C18H34N4O5S (418.22497940000005)
Val Gly Met Leu
C18H34N4O5S (418.22497940000005)
Val Ile Gly Met
C18H34N4O5S (418.22497940000005)
Val Ile Met Gly
C18H34N4O5S (418.22497940000005)
Val Ile Ser Thr
Val Ile Thr Ser
Val Leu Gly Met
C18H34N4O5S (418.22497940000005)
Val Leu Met Gly
C18H34N4O5S (418.22497940000005)
Val Leu Ser Thr
Val Leu Thr Ser
Val Met Ala Val
C18H34N4O5S (418.22497940000005)
Val Met Gly Ile
C18H34N4O5S (418.22497940000005)
Val Met Gly Leu
C18H34N4O5S (418.22497940000005)
Val Met Ile Gly
C18H34N4O5S (418.22497940000005)
Val Met Leu Gly
C18H34N4O5S (418.22497940000005)
Val Met Val Ala
C18H34N4O5S (418.22497940000005)
Val Ser Ile Thr
Val Ser Leu Thr
Val Ser Thr Ile
Val Ser Thr Leu
Val Thr Ile Ser
Val Thr Leu Ser
Val Thr Ser Ile
Val Thr Ser Leu
Val Thr Thr Val
Val Thr Val Thr
Val Val Ala Met
C18H34N4O5S (418.22497940000005)
Val Val Cys Val
C18H34N4O5S (418.22497940000005)
Val Val Met Ala
C18H34N4O5S (418.22497940000005)
Val Val Thr Thr
Val Val Val Cys
C18H34N4O5S (418.22497940000005)
sodium 2,3-bis[(2-ethylhexyl)oxy]propyl sulphate
C19H39NaO6S (418.23649140000003)
6-((3-((tert-Butyldimethylsilyloxy)methyl)pyrrolidin-1-yl)methyl)-2-(trimethylsilyl)furo[3,2-b]pyrid
C22H38N2O2Si2 (418.24716879999994)
butyl prop-2-enoate, methyl 2-methylprop-2-enoate, 2-methylprop-2 -enoic acid, styrene
[5-[(4,4-dimethoxypiperidin-1-yl)methyl]-1-[(2-methylpropan-2-yl)oxycarbonyl]indol-2-yl]boronic acid
sodium 2-[(2-ethylhexyl)oxy]-1-[[(2-ethylhexyl)oxy]methyl]ethyl sulphate
C19H39NaO6S (418.23649140000003)
tert-butyl 4-((4-chloro-5,5-dimethyl-3,4,5,6-tetrahydro-[1,1-biphenyl]-2-yl)methyl)piperazine-1-carboxylate
N-(1-adamantylmethyl)-2-chloro-5-[3-(3-hydroxypropylamino)propyl]benzamide
Palosuran
C25H30N4O2 (418.23686399999997)
C78274 - Agent Affecting Cardiovascular System > C29707 - Vasodilating Agent
Caseargrewiin D
A diterpenoid of the clerodane group isolated from the bark of Casearia grewiifolia and has been shown to exhibit antimalarial and antimycobacterial activity.
21-Acetoxy-11beta,17-dihydroxy-6alpha-methylpregn-4-ene-3,20-dione
3-(2-Amino-6-Benzoylquinazolin-3(4h)-Yl)-N-Cyclohexyl-N-Methylpropanamide
C25H30N4O2 (418.23686399999997)
1-(9Z,12Z)-octadecadienylglycerone 3-phosphate
A 1-alkylglycerone 3-phosphate in which the alkyl group is specified as (9Z,12Z)-octadecadienyl.
Phenylalanyl-prolyl-arginine
N-(5-{3-[(5-Amino-pentyl)-hydroxy-carbamoyl]-propionylamino}-pentyl)-N-hydroxy-succinamic acid
2-[2-[3-[Decanoyl(hydroxy)amino]propylamino]-2-oxoethyl]-2-hydroxybutanedioic acid
15,17-Epoxy-16-hydroxy macrolactin A
A natural product found in Bacillus species.
6-(4-Benzoyl-1-piperazinyl)-3,3-dimethyl-8-propan-2-yl-1,4-dihydropyrano[3,4-c]pyridine-5-carbonitrile
C25H30N4O2 (418.23686399999997)
N-{3-cyano-4-[4-(4-methoxyphenyl)piperazin-1-yl]phenyl}cyclohexanecarboxamide
C25H30N4O2 (418.23686399999997)
1-(5-Isoquinolinylmethyl)-4-[(3-methoxyphenyl)methyl]-4-piperidinecarboxylic acid ethyl ester
(1S,2E,7R,10Z,12E,15R,16E,18Z,21R,23R,24R)-15,23,24-trihydroxy-7-methyl-8,25-dioxabicyclo[19.3.1]pentacosa-2,10,12,16,18-pentaen-9-one
1-[(2S,3S)-6-acetyl-2-(hydroxymethyl)-3-[4-(2-methylphenyl)phenyl]-1,6-diazaspiro[3.3]heptan-1-yl]-2-cyclopropylethanone
1-[(2R,3R)-6-acetyl-2-(hydroxymethyl)-3-[4-(2-methylphenyl)phenyl]-1,6-diazaspiro[3.3]heptan-1-yl]-2-cyclopropylethanone
1-[(2S,3R)-6-acetyl-2-(hydroxymethyl)-3-[4-(2-methylphenyl)phenyl]-1,6-diazaspiro[3.3]heptan-1-yl]-2-cyclopropylethanone
2-cyclopropyl-1-[(2R,3R)-2-(hydroxymethyl)-3-[4-[(E)-prop-1-enyl]phenyl]-1-(pyrimidin-5-ylmethyl)-1,6-diazaspiro[3.3]heptan-6-yl]ethanone
C25H30N4O2 (418.23686399999997)
2-cyclopropyl-1-[(2S,3S)-2-(hydroxymethyl)-3-[4-[(E)-prop-1-enyl]phenyl]-1-(pyrimidin-5-ylmethyl)-1,6-diazaspiro[3.3]heptan-6-yl]ethanone
C25H30N4O2 (418.23686399999997)
(2-hydroxy-2-oxo-1,3,2$l^{5}-dioxaphospholan-4-yl)methyl (9Z)-octadec-9-enoate
(2-hydroxy-2-oxo-1,3,2$l^{5}-dioxaphospholan-4-yl)methyl (11Z)-octadec-11-enoate
1-oleoyl-sn-glycerol 2,3-cyclic phosphate
A 1-acyl-sn-glycerol 2,3-cyclic phosphate having oleoyl as the 1-O-acyl group.
17-Hydroxy-6alpha-methylcorticosterone 21-acetate
13,17-Epoxy-16-hydroxy macrolactin A
A natural product found in Bacillus species.
1-Oleylglycerone 3-phosphate(2-)
A 1-alkylglycerone 3-phosphate(2-) obtained by deprotonation of the phosphate OH groups of 1-oleylglycerone 3-phosphate; major species at pH 7.3.
methyl 5-{[(1s,2s,4as,8ar)-1-(hydroxymethyl)-2,4a-dimethyl-5-methylidene-hexahydro-2h-naphthalen-1-yl]methyl}-2,4-dihydroxy-3-methoxybenzoate
(2r,3r,3ar,4s,7s,7ar)-7,7a-dimethyl-4'-methylidene-4-[(2-methylpropanoyl)oxy]-2'-oxo-hexahydro-1h-spiro[indene-2,3'-oxolan]-3-yl (2z)-2-methylbut-2-enoate
(2s,4ar,6r,7r)-6-(acetyloxy)-7-(3-methoxy-3-oxoprop-1-en-2-yl)-1,4a-dimethyl-3,4,5,6,7,8-hexahydro-2h-naphthalen-2-yl (2e)-3-methylpent-2-enoate
[3-(acetyloxy)-1-[2-(furan-3-yl)ethyl]-6-hydroxy-2,5,5-trimethyl-2,3,4,6,7,8-hexahydronaphthalen-1-yl]methyl acetate
11-ethoxy-4,15-dimethoxy-2,6,14,17-tetramethyl-10-oxatetracyclo[7.7.1.0²,⁷.0¹³,¹⁷]heptadeca-4,14-diene-3,16-dione
(1s,3r,3as,3bs,5ar,7s,9as,11ar)-1-acetyl-3,3b,7-trihydroxy-3a,6,6,9a,11a-pentamethyl-1h,2h,3h,5h,5ah,7h,8h,9h-cyclopenta[a]phenanthrene-4,11-dione
10,12,14-trihydroxy-22-(2-hydroxypropyl)-1-oxacyclodocosa-3,5,7,15,17,19-hexaen-2-one
4-[(1r,2s,4r,5s,6r,9s,10r,13s,15s)-4,9-dihydroxy-15-methoxy-5-methyl-16-oxapentacyclo[13.2.2.0¹,¹³.0²,¹⁰.0⁵,⁹]nonadecan-6-yl]-5h-furan-2-one
4-({1-[2-(furan-3-yl)ethyl]-3-hydroxy-1,4a,5-trimethyl-2,3,4,7,8,8a-hexahydronaphthalen-2-yl}methoxy)-4-oxobutanoic acid
[(1s,4s,5r,6r,9s,10r,12r,14r)-4,5,6-trihydroxy-3,11,11,14-tetramethyl-15-oxotetracyclo[7.5.1.0¹,⁵.0¹⁰,¹²]pentadeca-2,7-dien-7-yl]methyl 2-methylpropanoate
(2r)-2-[(2s,3r,4r)-3-{6-[(1r,2r,3s,5s)-3-hydroxy-2,3,5-trimethyl-4-oxocyclopentyl]hepta-1,3,5-trien-1-yl}-3,4-dimethyl-5-oxooxolan-2-yl]propanoic acid
1-[(1s,4s,6s,10r,11s)-11-(acetyloxy)-4-methyl-9-methylidene-5,12-dioxatricyclo[8.4.0.0⁴,⁶]tetradec-13-en-14-yl]-4-methylpent-3-en-1-yl acetate
5-[(1r,3as,3br,5as,7s,9ar,9bs,10r,11ar)-3a,5a,7,10-tetrahydroxy-9a,11a-dimethyl-dodecahydro-1h-cyclopenta[a]phenanthren-1-yl]pyran-2-one
4-[(1r,2s,5r,6r,9s,10r,13s,15r,16s,18s)-9,15-dihydroxy-18-methoxy-5-methyl-17-oxapentacyclo[14.2.1.0¹,¹³.0²,¹⁰.0⁵,⁹]nonadecan-6-yl]-5h-furan-2-one
5-[(1r,3as,3br,5as,7r,9ar,9bs,10r,11ar)-3a,5a,7,10-tetrahydroxy-9a,11a-dimethyl-dodecahydro-1h-cyclopenta[a]phenanthren-1-yl]pyran-2-one
(2r,3r,3ar,4s,7s,7ar)-7,7a-dimethyl-4'-methylidene-4-[(2-methylpropanoyl)oxy]-2'-oxo-hexahydro-1h-spiro[indene-2,3'-oxolan]-3-yl 3-methylbut-2-enoate
(1as,1bs,3r,3ar,5s,7br,9r,9ar)-3-(acetyloxy)-1a-(hydroxymethyl)-5,7b-dimethyl-5-[(2s)-oxiran-2-yl]-1h,1bh,2h,3h,3ah,4h,6h,8h,9h,9ah-cyclopropa[a]phenanthren-9-yl acetate
[(1r,2r,4s,5s,9r,10s,11s,13s)-11-(acetyloxy)-2-hydroxy-5,9-dimethyl-14-methylidene-15-oxotetracyclo[11.2.1.0¹,¹⁰.0⁴,⁹]hexadecan-5-yl]methyl acetate
6-(acetyloxy)-13-hydroxy-5,5,9-trimethyl-14-methylidene-15-oxotetracyclo[11.2.1.0¹,¹⁰.0⁴,⁹]hexadecan-11-yl acetate
6-(acetyloxy)-7-(3-methoxy-3-oxoprop-1-en-2-yl)-1,4a-dimethyl-3,4,5,6,7,8-hexahydro-2h-naphthalen-2-yl 3-methylpent-2-enoate
(1s,3r,5r,6as,7r,8r,10as)-1-(acetyloxy)-5-hydroxy-7,8-dimethyl-7-(3-methylpenta-2,4-dien-1-yl)-1h,3h,5h,6h,6ah,8h,9h,10h-naphtho[1,8a-c]furan-3-yl acetate
(1r,2e,4s,6e,8z,12r,16e,18e,20r,22r,24s)-4,20,22-trihydroxy-12-methyl-11,25-dioxabicyclo[22.1.0]pentacosa-2,6,8,16,18-pentaen-10-one
1,6-dihydroxy-8-(hydroxymethyl)-4,12,12,15-tetramethyl-5-oxotetracyclo[8.5.0.0²,⁶.0¹¹,¹³]pentadeca-3,8-dien-13-yl 2-methylpropanoate
16-acetoxy-7α-ethoxyroyleanone
{"Ingredient_id": "HBIN001781","Ingredient_name": "16-acetoxy-7\u03b1-ethoxyroyleanone","Alias": "NA","Ingredient_formula": "C24H34O6","Ingredient_Smile": "Not Available","Ingredient_weight": "NA","OB_score": "NA","CAS_id": "NA","SymMap_id": "NA","TCMID_id": "193","TCMSP_id": "NA","TCM_ID_id": "NA","PubChem_id": "NA","DrugBank_id": "NA"}
Bakkenolidc-K
{"Ingredient_id": "HBIN017533","Ingredient_name": "Bakkenolidc-K","Alias": "NA","Ingredient_formula": "C24H34O6","Ingredient_Smile": "CC=C(C)C(=O)OC1C2C(CCC(C2(CC13C(=C)COC3=O)C)C)OC(=O)C(C)C","Ingredient_weight": "NA","OB_score": "NA","CAS_id": "NA","SymMap_id": "NA","TCMID_id": "35675","TCMSP_id": "NA","TCM_ID_id": "NA","PubChem_id": "NA","DrugBank_id": "NA"}
[(1s,4s,4as,5r,7s,8r,8ar)-1,4,5,8-tetrahydroxy-7-isopropyl-4a-methyl-octahydronaphthalen-1-yl]methyl (2e)-3-phenylprop-2-enoate
4-({4-[2-(furan-3-yl)ethyl]-3-(hydroxymethyl)-4,8,8a-trimethyl-1,2,3,4a,5,6-hexahydronaphthalen-2-yl}oxy)-4-oxobutanoic acid
(1r,2r,4r,8r,9r,10s,13s,16r)-8-(acetyloxy)-2-hydroxy-5,5,9-trimethyl-14-methylidene-15-oxotetracyclo[11.2.1.0¹,¹⁰.0⁴,⁹]hexadecan-16-yl acetate
(1r)-1-[(1r,4s,6r,10r,11r)-11-(acetyloxy)-4-methyl-9-methylidene-5,12-dioxatricyclo[8.4.0.0⁴,⁶]tetradec-13-en-14-yl]-4-methylpent-3-en-1-yl acetate
7,7a-dimethyl-4'-methylidene-4-[(2-methylpropanoyl)oxy]-2'-oxo-hexahydro-1h-spiro[indene-2,3'-oxolan]-3-yl 3-methylbut-2-enoate
{2,5-dihydroxy-6-[(2e,4e,6e)-1-hydroxy-3,7,11-trimethyldodeca-2,4,6,10-tetraen-1-yl]-7-oxabicyclo[4.1.0]hept-3-en-3-yl}methyl acetate
(1r,2r,6r)-6-[(2e,6e,10e)-12-hydroxy-3,7,11-trimethyldodeca-2,6,10-trien-1-yl]-3-(hydroxymethyl)-5-oxo-7-oxabicyclo[4.1.0]hept-3-en-2-yl acetate
7,7a-dimethyl-4'-methylidene-4-[(2-methylpropanoyl)oxy]-2'-oxo-hexahydro-1h-spiro[indene-2,3'-oxolan]-3-yl 2-methylbut-2-enoate
(1r,2r,4r,7s,9r,10e,13r,15s,16s)-16-(acetyloxy)-4,8,8,11,15-pentamethyl-12-oxo-3-oxatetracyclo[11.3.0.0²,⁴.0⁷,⁹]hexadec-10-en-13-yl acetate
[2,5-dihydroxy-6-(1-hydroxy-3,7,11-trimethyldodeca-2,4,6,10-tetraen-1-yl)-7-oxabicyclo[4.1.0]hept-3-en-3-yl]methyl acetate
5-[(1r,3as,3bs,4s,5as,7s,9as,9bs,11s,11as)-3a,4,7,11-tetrahydroxy-9a,11a-dimethyl-tetradecahydrocyclopenta[a]phenanthren-1-yl]pyran-2-one
[5-hydroxy-6-(1-hydroxy-3,7,11-trimethyldodeca-2,6,10-trien-1-yl)-2-oxo-7-oxabicyclo[4.1.0]hept-3-en-3-yl]methyl acetate
[(1as,1bs,3r,3ar,5s,7br,9r,9ar)-9-(acetyloxy)-3-hydroxy-5,7b-dimethyl-5-[(2s)-oxiran-2-yl]-1h,1bh,2h,3h,3ah,4h,6h,8h,9h,9ah-cyclopropa[a]phenanthren-1a-yl]methyl acetate
[(1s,2s,3r,4ar,6r,8as)-3-(acetyloxy)-1-[2-(furan-3-yl)ethyl]-6-hydroxy-2,4a-dimethyl-5-methylidene-hexahydro-2h-naphthalen-1-yl]methyl acetate
[(1r,2s,4s,5s,9r,10s,11r,13r)-11-(acetyloxy)-2-hydroxy-5,9-dimethyl-14-methylidene-15-oxotetracyclo[11.2.1.0¹,¹⁰.0⁴,⁹]hexadecan-5-yl]methyl acetate
[(1r,2s,3s,8ar,10ar)-2-(acetyloxy)-3-hydroxy-1-isopropyl-8a,10a-dimethyl-6-oxo-1h,2h,3h,7h,8h,9h,10h-cyclohexa[f]azulen-5-yl]methyl acetate
(1r,2r)-6-[(2e,6e,10e)-12-hydroxy-3,7,11-trimethyldodeca-2,6,10-trien-1-yl]-3-(hydroxymethyl)-5-oxo-7-oxabicyclo[4.1.0]hept-3-en-2-yl acetate
n-(2-{3'-[2-(dimethylamino)ethyl]-5'-hydroxy-1'h-[1,4'-biindol]-3-yl}ethyl)-n-methylacetamide
C25H30N4O2 (418.23686399999997)